These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17085314)

  • 1. Rituximab responsive refractory acute graft-versus-host disease.
    Kamble R; Oholendt M; Carrum G
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1201-2. PubMed ID: 17085314
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
    Benson DM; Smith MK; Krugh D; Devine SM
    Bone Marrow Transplant; 2008 Mar; 41(6):595-6. PubMed ID: 18037934
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.
    von Bonin M; Oelschlägel U; Radke J; Stewart M; Ehninger G; Bornhauser M; Platzbecker U
    Transplantation; 2008 Sep; 86(6):875-9. PubMed ID: 18813113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of refractory chronic GVHD with rituximab: a GITMO study.
    Zaja F; Bacigalupo A; Patriarca F; Stanzani M; Van Lint MT; Filì C; Scimè R; Milone G; Falda M; Vener C; Laszlo D; Alessandrino PE; Narni F; Sica S; Olivieri A; Sperotto A; Bosi A; Bonifazi F; Fanin R;
    Bone Marrow Transplant; 2007 Aug; 40(3):273-7. PubMed ID: 17549053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease.
    Szabolcs P; Reese M; Yancey KB; Hall RP; Kurtzberg J
    Bone Marrow Transplant; 2002 Sep; 30(5):327-9. PubMed ID: 12209356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
    Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin.
    Klein SA; Bug G; Mousset S; Hofmann WK; Hoelzer D; Martin H
    Br J Haematol; 2011 Jul; 154(1):143-6. PubMed ID: 21477160
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute graft-versus-host disease in children.
    Jacobsohn DA
    Bone Marrow Transplant; 2008 Jan; 41(2):215-21. PubMed ID: 17934526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus.
    Ziemer M; Gruhn B; Thiele JJ; Elsner P
    J Am Acad Dermatol; 2004 Jun; 50(6):946-8. PubMed ID: 15153900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients.
    Hui CH; Sia H; Mangos H; Horvath N; Lee H; Lewis I; Hughes T; To LB; Bardy P
    Bone Marrow Transplant; 2008 Feb; 41(4):409-10. PubMed ID: 18026147
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
    Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
    Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation.
    Miura Y; Narimatsu H; Kami M; Kusumi E; Matsumura T; Yuji K; Wake A; Miyakoshi S; Taniguchi S
    Bone Marrow Transplant; 2006 Oct; 38(8):577-9. PubMed ID: 16953206
    [No Abstract]   [Full Text] [Related]  

  • 16. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell involvement in chronic graft-versus-host disease.
    Kapur R; Ebeling S; Hagenbeek A
    Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
    Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab as salvage therapy for refractory chronic GVHD.
    Mohty M; Marchetti N; El-Cheikh J; Faucher C; Fürst S; Blaise D
    Bone Marrow Transplant; 2008 May; 41(10):909-11. PubMed ID: 18278073
    [No Abstract]   [Full Text] [Related]  

  • 20. Rash and GI symptoms on day +36.
    Weisdorf D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1405-6. PubMed ID: 17950925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.